WI
BIIB icon

Wintrust Investments’s Biogen BIIB Stock Holding History

Wintrust Investments’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,015
Closed -$269K – 354
2020
Q2 		$269K Buy
+1,015
New +$305K 0.04% 284
2019
Q4 		– Sell
-998
Closed -$243K – 358
2019
Q3 		$243K Buy
+998
New +$232K 0.04% 315

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wintrust Investments's BIIB Position: Q3 2020 in Review

Wintrust Investments sold out of Biogen (BIIB) in Q3 2020, closing a stake of 1,015 shares — an estimated $269K sold.

Wintrust Investments first reported a position in BIIB in Q3 2019 and held it in 2 quarters. The position peaked at $269K in Q2 2020. 1,051 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.

  • Wintrust Investments reported no remaining Biogen position as of Q3 2020 after selling out during the quarter.
  • Wintrust Investments sold 1,015 Biogen shares in Q3 2020, an estimated $269K.
  • Wintrust Investments first reported a position in Biogen in Q3 2019 and held it in 2 quarters.
  • Wintrust Investments's Biogen position peaked at $269K in Q2 2020.
  • 1,051 funds tracked by Wall St. Rank held Biogen as of Q3 2020.

Based on Wintrust Investments's 13F filing for Q3 2020, filed 12 Nov 2020.